Nicole LaBrosse - Feb 12, 2025 Form 4 Insider Report for HALOZYME THERAPEUTICS, INC. (HALO)

Role
SVP, CHIEF FINANCIAL OFFICER
Signature
/s/ James R. Oehler, Attorney-in-Fact
Stock symbol
HALO
Transactions as of
Feb 12, 2025
Transactions value $
$0
Form type
4
Date filed
2/14/2025, 06:09 PM
Previous filing
Jul 23, 2024
Next filing
Feb 18, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HALO Performance Stock Units Award $0 +6.05K +53.26% $0.00 17.4K Feb 12, 2025 Common Stock 6.05K $0.00 Direct F1
transaction HALO Performance Stock Units Award $0 +5.22K +176.21% $0.00 8.18K Feb 12, 2025 Common Stock 5.22K $0.00 Direct F2
transaction HALO Performance Stock Unit Award $0 +6.94K $0.00 6.94K Feb 12, 2025 Common Stock 6.94K $0.00 Direct F3
transaction HALO Performance Stock Units Award $0 +28.7K $0.00 28.7K Feb 12, 2025 Common Stock 28.7K $0.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 16, 2022 that included a performance measurement period ending December 31, 2024. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date.
F2 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 16, 2023 that included a performance measurement period ending December 31, 2024. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date.
F3 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 23, 2024 that included a performance measurement period ending December 31, 2024. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date.